Hyderabad based pharmaceutical major Dr Reddy's Laboratories has expanded the pilot launch project of the Russian Sputnik V COVID-19 vaccine to over 50 cities and towns in the country, reports Economic Times.
Taking to Twitter, the company said, "Starting initially in Hyderabad today, the soft launch rollout of Sputnik V has scaled up speedily and reached cities and towns all over India- including but not limited to Hyderabad, Vizag, Bengaluru, Mumbai, Navi Mumbai, Kolkata, Delhi, NCR, Chennai, Miryalaguda, Vijayawada, Baddi, Kolhapur, Kochi, Raipur, Chandigarh, Pune, Nagpur, Nashik."
The company also said that it will strengthen the commercial rollout of the Russian vaccine in the coming weeks. It has partnered with major hospitals across the nation for this purpose.
Dr Reddy's has a pact with the Russian Direct Investment Fund (RDIF) to sell 125 million people doses (250 million vials) of the vaccine in India. It had also recently received nearly three million doses.
It should be noted that the said vaccine has been developed by Russia's Gamaleya National Research Institute of Epidemiology and Microbiology.
An appeal from Swarajya
At Swarajya, we rely on our readers' support through subscriptions to sustain our media platform. Unlike larger conglomerates, we are unable to relentlessly chase advertising money — our model is largely built on your patronage.
Your support has never been more crucial. We work tirelessly to deliver 10-15 high-quality articles daily, ensuring you receive insightful content from 7 AM to 10 PM.
If you believe India's story has to be articulated in a way it has never been done before without shrugging it off, become a patron (or) subscribe now for ₹̶2̶4̶0̶0̶ ₹1999 and get 12 print issues, unlimited digital access for 1 year, a special India that is Bharat T-shirt (Offer ends soon).
We are counting on you!